| Low-dose naltrexone for disease prevention and quality of life. | |
| | |
MedLine Citation:
|
PMID: 19041189 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The use of low-dose naltrexone (LDN) for the treatment and prophylaxis of various bodily disorders is discussed. Accumulating evidence suggests that LDN can promote health supporting immune-modulation which may reduce various oncogenic and inflammatory autoimmune processes. Since LDN can upregulate endogenous opioid activity, it may also have a role in promoting stress resilience, exercise, social bonding, and emotional well-being, as well as amelioration of psychiatric problems such a autism and depression. It is proposed that LDN can be used effectively as a buffer for a large variety of bodily and mental ailments through its ability to beneficially modulate both the immune system and the brain neurochemistries that regulate positive affect. |
| | |
Authors:
|
Norman Brown; Jaak Panksepp |
Related Documents
:
|
11887609 - Infertility and the role of psychotherapy. 20963469 - The use of a surveillance system to measure changes in mental health in australian adul... 22014669 - Unmet needs for home and community-based services among persons with disabilities in m... 9640029 - Operational stress control in the former yugoslavia: a joint endeavor. 2230759 - Classification of natural and supernatural causes of mental distress. development of a ... 8852019 - Occupational stress among senior police officers. 10122449 - How contracting will force us to ask questions we never asked before. 9413789 - Practitioner review: physical investigations in mental retardation. 7276549 - Moderator variables in life stress and illness relationship. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2008-11-28 |
Journal Detail:
|
Title: Medical hypotheses Volume: 72 ISSN: 0306-9877 ISO Abbreviation: Med. Hypotheses Publication Date: 2009 Mar |
Date Detail:
|
Created Date: 2009-02-09 Completed Date: 2009-04-28 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7505668 Medline TA: Med Hypotheses Country: Scotland |
Other Details:
|
Languages: eng Pagination: 333-7 Citation Subset: IM |
Affiliation:
|
Department of Humanities and Social Sciences, Embry-Riddle Aeronautical University, Daytona Beach, FL 32114, United States. NPHbrown@aol.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cytokines
/
immunology* Dose-Response Relationship, Drug Humans Inflammation / immunology*, prevention & control* Models, Immunological Naltrexone / administration & dosage* Narcotic Antagonists / administration & dosage Neoplasms / immunology*, prevention & control* Quality of Life* |
| Chemical | |
Reg. No./Substance:
|
0/Cytokines; 0/Narcotic Antagonists; 16590-41-3/Naltrexone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Why do we respond so differently? Reviewing determinants of human salivary cortisol responses to cha...
Next Document: Comparison of chromosomal aberrations between primary tumors and their synchronous lymph-node metast...